New RFP: increasing the understanding of the impact of underlying medical conditions and other risk factors in people who are at increased risk of developing severe outcomes from COVID-19
This independent, competitive medical education grant, intended to improve patient outcomes, been announced by Pfizer. Applications are due 22nd September 2022.